Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis

    Diabetes, Obesity and Metabolism Date published:

  • Modifying the Health Star Rating nutrient profiling algorithm to account for ultra-processing

    Nutrition & Dietetics Date published:

  • Estimated Health Benefits, Costs, and Cost-Effectiveness of Implementing WHO Global Sodium Benchmarks in India

    Current Developments in Nutrition Date published:

  • Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial

    European Journal of Heart Failure Date published:

  • Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

    Circulation Date published:

  • Switches in food and beverage product purchases can reduce greenhouse gas emissions in Australia

    Nature Food Date published:

  • Speed of ethics and governance approvals in Australia before and after the COVID-19 pandemic: a cross-sectional study

    Unknown Date published:

  • Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes

    Hypertension Date published:

  • Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines

    Hypertension Date published:

  • The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants

    European Journal of Clinical Nutrition Date published:

  • The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study

    Journal of Human Hypertension Date published:

  • Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities

    JAMA Network Open Date published:

  • Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

    Circulation Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

    Kidney International Reports Date published:

  • The potential for current sodium and potassium production to support a global switch to the use of potassium-enriched salt: a desktop research study

    Public Health Nutrition Date published:

  • Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

    International Journal of Cardiology Date published: